No definition available.
Other and unspecified immunodeficiencies with predominantly antibody defects
DOID EFO Endpoint Browser PheWeb
D3_IMMUDEFANTIBODYNAS
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
441 |
4. Check minimum number of eventsNone |
441 |
5. Include endpointsNone |
441 |
6. Filter based on genotype QC (FinnGen only) |
441 |
Control definitions (FinnGen only)
- Control exclude
- D3_IMMUNEMECHANISM
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Other and unspecified immunodeficiencies with predominantly antibody defects
based on the number of shared cases.
Similar with more cases:
- Immunodeficiency with predominantly antibody defects
- Immunodeficiencies
- Certain disorders involving the immune mechanism
- Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
- Any operation in hilmo
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 1635 | 939 | 695 |
| Only index persons | 1497 | 874 | 623 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.02 | 0.03 | 0.02 |
| Only index persons | 0.03 | 0.03 | 0.02 |
| Median age at first event (years) | |||
| Whole population | 44.50 | 48.34 | 39.35 |
| Only index persons | 44.51 | 48.28 | 39.22 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 441 | 292 | 149 |
| Unadjusted period prevalence (%) | 0.09 | 0.10 | 0.07 |
| Median age at first event (years) | 49.39 | 49.73 | 48.73 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 404
- Matched controls
- 4041
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D80.9
ICD-10 Finland
Immunodeficiency with predominantly antibody defects, unspecified
+∞
302.5
251
*
D80.8
ICD-10 Finland
Other immunodeficiencies with predominantly antibody defects
+∞
215.5
187
*
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
+∞
151.9
136
*
120
Kela drug reimbursment
Hypogammaglobulinaemia
+∞
149.5
134
*
J06BA01
ATC
immunoglobulins, normal human, for extravascular adm.; systemic
+∞
142.3
128
*
ZX120
NOMESCO Finland
Intravenous
17.1
109.1
192
203
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
29.3
99.8
138
70
WW200
NOMESCO Finland
Immunization
36.5
89.7
116
44
D80.3
ICD-10 Finland
Selective deficiency of immunoglobulin G [IgG] subclasses
+∞
87.8
81
*
6BA02
NOMESCO Finland
NA
357.3
87.3
85
*
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
23.0
79.4
118
71
GD1AA
NOMESCO Finland
Thorax X-ray examination
7.7
76.0
300
1104
H02AB06
ATC
prednisolone; systemic
7.5
71.1
316
1310
J01MA14
ATC
moxifloxacin; systemic
11.5
67.1
137
172
J01MA12
ATC
levofloxacin; systemic
7.8
65.9
183
386
D80.0
ICD-10 Finland
Hereditary hypogammaglobulinaemia
+∞
65.4
61
*
J18.9
ICD-10 Finland
Pneumonia, unspecified
7.5
65.1
189
424
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
31.8
64.6
86
34
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
12.1
63.6
125
144
TDM10
NOMESCO Finland
Puncture of maxillary antrum
23.1
60.0
88
48
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
20.4
58.2
89
55
TPH04
NOMESCO Finland
Cathetrisation of vein
6.4
57.7
193
506
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
7.3
53.3
148
296
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
11.6
50.8
100
111
C01CA24
ATC
epinephrine; parenteral
10.0
48.9
105
137
H02AB07
ATC
prednisone; oral
6.7
48.3
143
306
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
5.0
46.7
201
666
R03DC03
ATC
montelukast; oral
5.7
45.8
158
406
J45.0
ICD-10 Finland
Predominantly allergic asthma
7.9
45.7
115
193
J45.9
ICD-10 Finland
Asthma, unspecified
5.5
43.6
156
414
J47
ICD-10 Finland
Bronchiectasis
28.6
43.4
59
24
J45.1
ICD-10 Finland
Nonallergic asthma
8.5
42.4
100
150
R50.9
ICD-10 Finland
Fever, unspecified
5.5
41.6
146
376
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
13.9
41.3
73
63
J01FA06
ATC
roxithromycin; oral
4.3
41.2
252
1132
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
4.3
39.7
204
771
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
5.1
39.5
149
412
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
4.9
39.0
155
453
TGC00
NOMESCO Finland
Bronchial lavation
23.0
38.7
56
28
R03BA02
ATC
budesonide; inhalant
4.9
37.5
149
432
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
9.9
37.4
79
97
R03BB04
ATC
tiotropium bromide; inhalant
7.4
36.8
95
161
R4110
NOMESCO Finland
Physiotherapy
4.2
36.7
188
693
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
8.4
36.7
86
126
UGC12
NOMESCO Finland
Flexible bronchoscopy
9.9
36.5
77
94
J01.0
ICD-10 Finland
Acute maxillary sinusitis
4.2
34.8
171
600
XW000
NOMESCO Finland
Bone marrow biopsy
13.4
34.7
62
54
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
9.6
34.1
73
91
R03AK06
ATC
salmeterol and fluticasone; inhalant
5.1
32.8
117
296
D83.9
ICD-10 Finland
Common variable immunodeficiency, unspecified
+∞
32.7
31
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
6.3
31.9
93
184
R03AC02
ATC
salbutamol; inhalant
3.7
31.8
289
1645
H02AB09
ATC
hydrocortisone; systemic
14.3
31.4
54
43
R03DA04
ATC
theophylline; systemic, rectal
11.3
30.1
58
59
JN4BD
NOMESCO Finland
Extensive body CT
5.8
29.7
92
195
R03AC12
ATC
salmeterol; inhalant
10.1
29.7
61
70
J46
ICD-10 Finland
Status asthmaticus
13.7
29.7
52
43
ZX108
NOMESCO Finland
Inhalation
61.6
29.6
34
6
J01FA10
ATC
azithromycin; systemic
3.7
29.5
314
1963
J05AB11
ATC
valaciclovir; oral
5.0
29.3
106
269
H02AB04
ATC
methylprednisolone; systemic
4.6
29.0
115
320
R03AL02
ATC
salbutamol and ipratropium bromide; inhalant
52.8
28.9
34
7
WE300
NOMESCO Finland
Profylactive therapy of malignancy with biomoidiers
+∞
28.5
27
*
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
3.4
28.4
282
1645
WX408
NOMESCO Finland
General anesthesy, balanced
3.5
28.1
180
756
R03BB01
ATC
ipratropium bromide; inhalant
12.8
27.8
50
44
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
9.1
27.6
60
76
R03AK04
ATC
salbutamol and sodium cromoglicate; inhalant
66.9
27.4
31
5
WW500
NOMESCO Finland
Blood transfusion
10.3
27.2
55
61
R03AC13
ATC
formoterol; inhalant
8.8
27.2
60
78
A03FA01
ATC
metoclopramide; systemic, rectal
3.9
27.1
138
478
R01AD09
ATC
mometasone; nasal
3.2
26.7
254
1410
XF400
NOMESCO Finland
ECG with 12 standard connections
4.2
26.6
118
363
D80.2
ICD-10 Finland
Selective deficiency of immunoglobulin A [IgA]
+∞
26.3
25
*
J02AC01
ATC
fluconazole; systemic
3.1
25.9
229
1197
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
3.1
25.6
256
1451
R01AD08
ATC
fluticasone; nasal
3.2
25.5
181
810
J01MA02
ATC
ciprofloxacin; systemic
3.1
25.1
201
975
R05
ICD-10 Finland
Cough
3.7
25.0
129
449
UDH02
NOMESCO Finland
Rhinopharyngoscopy
5.8
24.7
75
153
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
6.2
24.7
70
131
R01AD05
ATC
budesonide; nasal
5.7
24.5
75
155
J32.4
ICD-10 Finland
Chronic pansinusitis
20.6
24.4
36
19
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
5.3
24.2
79
176
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
9.1
23.7
51
63
J01FA09
ATC
clarithromycin; systemic
3.0
23.6
189
905
J01FF01
ATC
clindamycin; systemic
3.2
23.4
161
692
ZXA10
NOMESCO Finland
Bilateral
3.6
23.2
126
453
Z01.8
ICD-10 Finland
Other specified special examinations
3.4
23.1
137
526
D83.0
ICD-10 Finland
Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function
+∞
23.1
22
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
6.8
22.9
60
101
R03AK07
ATC
formoterol and budesonide; inhalant
3.4
22.7
133
507
D84.18
ICD-10 Finland
Other specified defect in the complement system
+∞
22.1
21
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
16.5
21.9
35
23
L03AA02
ATC
filgrastim; parenteral
11.6
21.9
41
39
R06.0
ICD-10 Finland
Dyspnoea
3.3
21.7
135
535
ZX112
NOMESCO Finland
Subcutaneous
22.3
21.6
31
15
M05BA04
ATC
alendronic acid; oral
6.4
21.6
59
105
J32.9
ICD-10 Finland
Chronic sinusitis, unspecified
25.9
21.1
29
12
J05AB01
ATC
aciclovir; systemic
3.3
21.1
129
503
D70.82
ICD-10 Finland
Drug-induced neutropenia
16.0
21.1
34
23
J45.8
ICD-10 Finland
Mixed asthma
10.1
20.9
42
46
XQ800
NOMESCO Finland
Prick test
5.0
20.9
72
169
A02BC02
ATC
pantoprazole; systemic
2.8
20.8
289
1896
R03BA05
ATC
fluticasone; inhalant
3.3
20.8
127
495
J01DA06
ATC
[U] cefuroxime; systemic
3.6
20.4
103
346
J01AA02
ATC
doxycycline; systemic
3.3
20.3
341
2509
H04.10
ICD-10 Finland
Dry eye syndrome
4.8
20.2
72
175
A07AA02
ATC
nystatin; oral
5.5
20.1
62
128
N03AX16
ATC
pregabalin; oral
3.1
20.0
132
541
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.7
20.0
98
321
XA800
NOMESCO Finland
Neuropsychological investigation
6.9
19.9
51
83
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
4.9
19.9
69
163
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
2.7
19.8
194
1022
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
26.2
19.8
27
11
J01FA15
ATC
telithromycin; oral
4.2
19.5
81
229
R03AK11
ATC
formoterol and fluticasone; inhalant
10.4
19.3
38
40
R06AE07
ATC
cetirizine; oral
2.6
19.1
227
1326
J31.0
ICD-10 Finland
Chronic rhinitis
5.1
19.0
63
141
GD1AD
NOMESCO Finland
Thorax CT examination
8.8
19.0
41
51
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
3.6
18.9
96
322
2790C
ICD-9 Finland
Disorders involving the immune mechanism, Deficiency of humoral immunity[DEFICIENTIA IMMUNOGLOBULINI ALIA]
+∞
18.9
18
*
N02AX02
ATC
tramadol; systemic, rectal
2.6
18.8
203
1121
R03BA01
ATC
beclometasone; inhalant
3.7
18.7
89
283
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.7
18.7
188
997
UJF30
NOMESCO Finland
Ileoscopy through colon
4.3
18.6
73
195
L04AX01
ATC
azathioprine; systemic
7.6
18.5
44
64
J01DB01
ATC
cefalexin; oral
3.5
18.2
359
2801
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
6.3
18.2
50
89
TAB00
NOMESCO Finland
Lumbar puncture
6.4
18.2
49
85
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
2.7
18.0
159
773
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
5.9
18.0
52
99
ZX114
NOMESCO Finland
Intramuscular
12.3
17.8
32
28
D80.6
ICD-10 Finland
Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinaemia
+∞
17.8
17
*
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
14.0
17.7
30
23
UJF32
NOMESCO Finland
Coloscopy
2.9
17.7
131
572
1XC02
NOMESCO Finland
NA
19.7
17.6
26
14
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
16.9
17.3
27
17
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
52.4
17.1
20
*
WZC30
NOMESCO Finland
Teaching
3.5
17.0
86
286
R03AK08
ATC
formoterol and beclometasone; inhalant
7.1
17.0
42
65
R01BA52
ATC
pseudoephedrine, combinations; oral
2.6
16.9
163
830
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.6
16.9
173
909
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
10.8
16.7
32
32
R03BA08
ATC
ciclesonide; inhalant
4.2
16.7
67
182
A01AB09
ATC
miconazole; local oral
4.3
16.6
65
172
D84.9
ICD-10 Finland
Immunodeficiency, unspecified
176.9
16.6
17
*
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
6.1
16.6
46
83
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
3.6
16.4
82
269
R03DC01
ATC
zafirlukast; oral
13.6
16.4
28
22
N02AA05
ATC
oxycodone; systemic
3.7
16.3
78
247
E0000UV
ATC
NA
2.5
16.3
198
1135
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
3.0
16.3
108
436
C03CA01
ATC
furosemide; systemic
2.9
16.1
115
486
N03AX12
ATC
gabapentin; oral
3.3
15.9
88
312
ZXA00
NOMESCO Finland
Right side
2.7
15.7
135
638
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
15.6
15.6
25
17
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
39.7
15.5
19
5
J01DA01
ATC
[U] cefalexin; systemic
2.4
15.4
277
1916
J20
ICD-10 Finland
Acute bronchitis
3.9
15.3
67
196
4730A
ICD-9 Finland
Chronic sinusitis, Maxillary
14.7
15.2
25
18
R03AC03
ATC
terbutaline; inhalant
3.2
15.2
88
322
EP1AE
NOMESCO Finland
Neck ultrasound examination
4.6
15.1
54
131
TPX10
NOMESCO Finland
Implantation of vascular injection port
8.3
14.9
33
43
L04AA06
ATC
mycophenolic acid; systemic
13.9
14.9
25
19
S01GX01
ATC
cromoglicic acid; ophthalmic
2.7
14.8
125
580
A41.9
ICD-10 Finland
Sepsis, unspecified
7.4
14.7
35
51
D86.0
ICD-10 Finland
Sarcoidosis of lung
+∞
14.7
14
*
WVC10
NOMESCO Finland
Subcutaneous infusion of drugs
37.5
14.6
18
5
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.7
14.4
121
558
N06AX21
ATC
duloxetine; oral
3.5
14.1
71
233
N05CF01
ATC
zopiclone; oral
2.4
14.1
147
764
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
4.2
14.0
55
146
R4120
NOMESCO Finland
Occupational therapy
5.0
14.0
46
102
R1250
NOMESCO Finland
Evaluation of functional capability
10.6
13.7
26
26
A02BC01
ATC
omeprazole; systemic
2.5
13.6
132
659
A04AA01
ATC
ondansetron; systemic, rectal
4.5
13.5
49
120
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
4.3
13.5
51
130
R81
ICPC
Pneumonia
9.0
13.5
28
33
J45
ICD-10 Finland
Asthma
3.5
13.5
66
212
X59
ICD-10 Finland
Exposure to unspecified factor
2.8
13.5
101
433
ZXA05
NOMESCO Finland
Left side
2.5
13.1
123
600
RS221
NOMESCO Finland
NA
13.6
13.1
22
17
ZX121
NOMESCO Finland
Central venous catheter
29.5
13.1
17
6
D64.9
ICD-10 Finland
Anaemia, unspecified
4.0
13.0
53
146
B29
ICPC
Lymph/immune mech sympt/complt other
51.7
12.9
15
*
WX002
NOMESCO Finland
Sedation and analgesia
2.7
12.6
100
443
M04AA01
ATC
allopurinol; systemic
3.6
12.6
60
188
N05BA01
ATC
diazepam; systemic, rectal
3.0
12.6
79
303
D84.19
ICD-10 Finland
Unspecified defect in the complement system
+∞
12.6
12
*
M36.8*D80.1
ICD-10 Finland
Systemic disorders of connective tissue in hypogammaglobulinaemia
+∞
12.6
12
*
R03AK03
ATC
[D] fenoterol & other drugs for obstructive airway dis; inhalant
5.4
12.3
37
74
127
Kela drug reimbursment
Transplant complication
12.9
12.3
21
17
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
3.7
12.2
55
165
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
9.1
12.2
25
29
R01AD12
ATC
fluticasone furoate; nasal
2.3
12.1
154
867
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
3.9
12.0
51
145
R06AX27
ATC
desloratadine; oral
2.3
12.0
149
831
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
11.0
11.9
22
21
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
3.6
11.8
55
169
WZB00
NOMESCO Finland
Telephone receipt or other advice
2.3
11.8
146
810
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
3.0
11.8
71
264
R03BC03
ATC
nedocromil; inhalant
4.1
11.7
47
127
P01AB01
ATC
metronidazole; oral, rectal
2.1
11.7
183
1128
A28
ICPC
Limited function/disability NOS
3.2
11.7
65
228
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
31.0
11.7
15
5
R51.80
ICD-10 Finland
Headache
2.7
11.6
86
364
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
3.4
11.6
59
195
XG410
NOMESCO Finland
Flow-volume spirometry
5.3
11.6
35
71
D86.8
ICD-10 Finland
Sarcoidosis of other and combined sites
+∞
11.5
11
*
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
2.9
11.5
76
300
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
11.0
11.4
21
20
Z50.1
ICD-10 Finland
Other physical therapy
4.8
11.4
38
86
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
3.3
11.4
60
204
D70.89
ICD-10 Finland
Neutropenic splenomegaly
13.2
11.2
19
15
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.2
11.2
63
223
R06AE09
ATC
levocetirizine; oral
2.6
11.2
87
379
Q79.6
ICD-10 Finland
Ehlers-Danlos syndrome
25.8
11.2
15
6
DNB20
NOMESCO Finland
Endoscopic ethmoidectomy
7.0
11.2
27
41
XX9AW
NOMESCO Finland
Production of copy from X-ray picture
5.8
11.1
31
57
JN3BD
NOMESCO Finland
Extensive abdominal CT
3.1
11.0
63
226
DM1AI
NOMESCO Finland
Cone beam CT of paranasal sinus
8.2
11.0
24
31
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
3.2
10.9
58
198
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
28.9
10.8
14
5
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
3.3
10.8
57
194
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
3.8
10.8
46
132
J01.4
ICD-10 Finland
Acute pansinusitis
22.2
10.7
15
7
H66.0
ICD-10 Finland
Acute suppurative otitis media
3.2
10.7
59
205
A02BC05
ATC
esomeprazole; systemic
2.1
10.6
182
1150
UJD02
NOMESCO Finland
Gastroscopy
5.4
10.5
31
61
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
3.1
10.5
59
209
A02BC03
ATC
lansoprazole; oral
2.2
10.5
129
705
WX892
NOMESCO Finland
Monitored bed care
3.6
10.5
48
146
D84.1
ICD-10 Finland
Defects in the complement system
+∞
10.5
10
*
D86.2
ICD-10 Finland
Sarcoidosis of lung with sarcoidosis of lymph nodes
+∞
10.5
10
*
R01AD58
ATC
fluticasone, combinations; inhalant, nasal
2.3
10.4
113
584
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
12.5
10.4
18
15
N06AA10
ATC
nortriptyline; systemic
9.2
10.4
21
24
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
3.1
10.4
59
211
JN4AD
NOMESCO Finland
Body CT examination
4.0
10.4
41
110
RD210
NOMESCO Finland
NA
5.9
10.3
28
50
J01FA01
ATC
erythromycin; systemic
2.6
10.3
79
341
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
7.2
10.2
24
35
N03AX11
ATC
topiramate; oral
6.8
10.2
25
39
R53
ICD-10 Finland
Malaise and fatigue
2.4
10.2
97
470
J10.1
ICD-10 Finland
Influenza with other respiratory manifestations, seasonal influenza virus identified
11.7
10.1
18
16
DCA20
NOMESCO Finland
Insertion of ventilating tube through tympanic membrane
5.2
10.1
31
64
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
3.0
10.1
59
215
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
15.1
10.1
16
11
R01AD01
ATC
beclometasone; nasal
2.6
10.1
82
364
H92.0
ICD-10 Finland
Otalgia
4.3
10.0
37
93
DPA30
NOMESCO Finland
Sphenotomy
41.1
10.0
12
*
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
3.4
10.0
50
163
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
3.5
9.9
46
142
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
20.6
9.9
14
7
A01AB04
ATC
amphotericin B; local oral
4.5
9.9
34
80
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.8
9.8
66
261
3AC01
NOMESCO Finland
NA
11.8
9.6
17
15
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
4.3
9.6
35
87
N03AE01
ATC
clonazepam; systemic
3.8
9.6
40
113
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
5.1
9.5
29
60
N05CD07
ATC
temazepam; oral
2.9
9.5
61
235
4930A
ICD-9 Finland
Asthma, Extrinsic asthma[EXTRINSIC ASTHMA SINE EXACERBATIONE]
18.1
9.5
14
8
J13
ICD-10 Finland
Pneumonia due to Streptococcus pneumoniae
18.1
9.5
14
8
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
4.6
9.5
32
74
ZX110
NOMESCO Finland
Intracutaneous
102.3
9.5
10
*
UJF92
NOMESCO Finland
Capsular endoscopy
8.4
9.4
20
25
602
Kela drug reimbursment
Children's severe malnutrition
30.8
9.4
12
*
D86.9
ICD-10 Finland
Sarcoidosis, unspecified
+∞
9.4
9
*
GD1DG
NOMESCO Finland
Extremely extensive MRI examination of pleura with high field magnet
+∞
9.4
9
*
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
2.2
9.4
106
553
A02BA02
ATC
ranitidine; systemic
2.4
9.4
92
449
J01DA08
ATC
[U] cefaclor; oral
2.6
9.4
71
304
M35.7
ICD-10 Finland
Hypermobility syndrome
9.9
9.4
18
19
SPAT1324
SPAT
Screening procedure
0.3
9.2
15
532
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
14.1
9.2
15
11
M79.0
ICD-10 Finland
Rheumatism, unspecified
5.0
9.2
29
62
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
3.0
9.2
56
208
A06AD11
ATC
lactulose; oral
2.8
9.2
61
241
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
2.2
9.1
110
591
4224
FHL
Endonasal anthrostomy
16.0
9.1
14
9
XG474
NOMESCO Finland
Exhalation nntrogen oxide
6.0
9.0
24
42
J32.8
ICD-10 Finland
Other chronic sinusitis
24.6
9.0
12
5
M80.4
ICD-10 Finland
Drug-induced osteoporosis with pathological fracture
24.6
9.0
12
5
J40
ICD-10 Finland
Bronchitis, not specified as acute or chronic
7.1
9.0
21
31
N06AA09
ATC
amitriptyline; systemic
3.0
8.9
54
199
N02BE01
ATC
paracetamol; systemic, rectal
2.3
8.9
343
2883
L28
ICPC
Limited function/disability (L)
2.7
8.9
65
272
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.4
8.9
82
387
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
9.8
8.9
17
18
R49.01
ICD-10 Finland
Functional dysphonia
5.1
8.8
27
56
AA1AD
NOMESCO Finland
CT of head and brain
2.3
8.8
95
485
R51.81
ICD-10 Finland
Facial pain NOS
7.5
8.8
20
28
H02AB02
ATC
dexamethasone; systemic
2.8
8.8
58
227
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
4.4
8.8
31
75
C09CA06
ATC
candesartan; oral
2.3
8.7
90
450
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
51.1
8.7
10
*
R11
ICD-10 Finland
Nausea and vomiting
3.1
8.7
48
167
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
11.9
8.6
15
13
R06AX22
ATC
ebastine; oral
2.3
8.6
90
454
A06AC01
ATC
ispaghula (psylla seeds); oral
2.2
8.6
103
551
DCA10
NOMESCO Finland
Paracentesis of tympanic membrane
9.3
8.6
17
19
ZX109
NOMESCO Finland
Instruction on medicine inhalation technique
16.7
8.6
13
8
R01AD11
ATC
triamcinolone; nasal
3.0
8.6
52
192
C83.9
ICD-10 Finland
Non-follicular (diffuse) lymphoma, unspecified
28.2
8.5
11
*
9823/3-C42.1
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow
28.2
8.5
11
*
JFA98
NOMESCO Finland
Other transluminal endoscopic local operation on intestine
8.1
8.4
18
23
J33.8
ICD-10 Finland
Other polyp of sinus
8.1
8.4
18
23
5BA08
NOMESCO Finland
NA
91.8
8.4
9
*
XF600
NOMESCO Finland
Bloodpressure measurement
3.1
8.4
45
155
N02CC03
ATC
zolmitriptan; nasal, oral
3.9
8.4
34
94
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
4.3
8.4
30
74
D86.1
ICD-10 Finland
Sarcoidosis of lymph nodes
+∞
8.4
8
*
KA1AE
NOMESCO Finland
Kidney ultrasound examination
7.3
8.3
19
27
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
7.8
8.2
18
24
M01AG02
ATC
tolfenamic acid; oral, rectal
2.3
8.2
78
373
M03BX01
ATC
baclofen; systemic
8.4
8.2
17
21
E000002
ATC
NA
2.6
8.1
63
271
DMB00
NOMESCO Finland
Endonasal trephine of maxillary antrum
12.0
8.1
14
12
NE1AA
NOMESCO Finland
Pelvis X-ray examination
3.7
8.1
35
102
WW300
NOMESCO Finland
Transfer of autologic stem cells
17.6
8.1
12
7
B28
ICPC
Limited function/disability (B)
17.6
8.1
12
7
RK110
NOMESCO Finland
NA
17.6
8.1
12
7
318
Kela drug reimbursment
Teriparatide
34.1
8.1
10
*
C82.9
ICD-10 Finland
Follicular lymphoma, unspecified
34.1
8.1
10
*
H05AA02
ATC
teriparatide; parenteral
34.1
8.1
10
*
4222
FHL
Endonasal etmoidectomy
34.1
8.1
10
*
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
5.7
8.1
22
40
SHB00
NOMESCO Finland
Prepation and fitting of bite rail to mouth
2.7
8.1
55
221
B99
ICD-10 Finland
Other and unspecified infectious diseases
10.3
8.1
15
15
N02CC01
ATC
sumatriptan; nasal, systemic, rectal
2.4
8.1
69
315
D59.1
ICD-10 Finland
Other autoimmune haemolytic anaemias
22.5
8.1
11
5
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
7.5
8.0
18
25
RS220
NOMESCO Finland
NA
7.5
8.0
18
25
Z71.8
ICD-10 Finland
Other specified counselling
2.1
8.0
111
628
H65.3
ICD-10 Finland
Chronic mucoid otitis media
5.4
8.0
23
45
J02AC02
ATC
itraconazole; systemic
2.2
7.9
87
445
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
13.4
7.9
13
10
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
3.0
7.9
45
161
J01.1
ICD-10 Finland
Acute frontal sinusitis
8.7
7.9
16
19
JN6AD
NOMESCO Finland
CT of torso and neck
11.1
7.8
14
13
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
11.1
7.8
14
13
J96.0
ICD-10 Finland
Acute respiratory failure
11.1
7.8
14
13
XX3DW
NOMESCO Finland
Time consuming IT work
2.9
7.8
46
169
XCK00
NOMESCO Finland
Perimetry
3.5
7.8
35
106
4930B
ICD-9 Finland
Asthma, Extrinsic asthma[EXTRINSIC ASTHMA CUM EXACERBATIONE]
15.4
7.8
12
8
J17.3*B59
ICD-10 Finland
Pneumonia due to Pneumocystis carinii
45.8
7.7
9
*
N06AX11
ATC
mirtazapine; oral
1.9
7.7
137
852
C07AB07
ATC
bisoprolol; oral
1.9
7.6
161
1063
J18.1
ICD-10 Finland
Lobar pneumonia, unspecified
12.2
7.6
13
11
4939X
ICD-9 Finland
Asthma, unspecified[ASTHMA BRONCHIALE NUD]
10.3
7.6
14
14
TK800
NOMESCO Finland
Hemodialysis
7.3
7.6
17
24
J01
ICD-10 Finland
Acute sinusitis
3.3
7.5
37
120
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
4.7
7.5
24
53
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
2.8
7.5
50
196
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
5.8
7.5
20
36
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
7.9
7.5
16
21
J20.5
ICD-10 Finland
Acute bronchitis due to respiratory syncytial virus
81.5
7.4
8
*
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.8
7.4
176
1210
A04AA02
ATC
granisetron; systemic, transdermal
3.2
7.4
37
122
L03AA14
ATC
lipegfilgrastim; parenteral
7.0
7.4
17
25
R05CB01
ATC
acetylcysteine; inhalant, oral
11.1
7.3
13
12
J84.8
ICD-10 Finland
Other specified interstitial pulmonary diseases
9.6
7.3
14
15
D06BB03
ATC
aciclovir; topical
3.9
7.3
29
79
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
4.3
7.3
26
64
M30.1
ICD-10 Finland
Polyarteritis with lung involvement [Churg-Strauss]
+∞
7.3
7
*
1XX32
NOMESCO Finland
NA
+∞
7.3
7
*
D89.89
ICD-10 Finland
Other specified disorders involving the immune mechanism, not elsewhere classified
+∞
7.3
7
*
C83.00
ICD-10 Finland
Lymphocytic lymphoma
+∞
7.3
7
*
D81.0
ICD-10 Finland
Severe combined immunodeficiency [SCID] with reticular dysgenesis
+∞
7.3
7
*
J06BA02
ATC
immunoglobulins, normal human, for intravascular adm.; systemic
+∞
7.3
7
*
2AX04
NOMESCO Finland
NA
+∞
7.3
7
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
16.1
7.3
11
7
R06AX13
ATC
loratadine; oral
2.1
7.3
83
434
M05BB03
ATC
alendronic acid and colecalciferol; oral
7.5
7.3
16
22
C10AC01
ATC
colestyramine; oral
5.2
7.2
21
42
M81.9
ICD-10 Finland
Osteoporosis, unspecified
4.7
7.2
23
51
G93.3
ICD-10 Finland
Postviral fatigue syndrome
30.6
7.2
9
*
TK810
NOMESCO Finland
Hemofiltration
30.6
7.2
9
*
C08DA01
ATC
verapamil; systemic
4.5
7.2
24
56
J01CA04
ATC
amoxicillin; systemic
2.0
7.1
339
2905
M01AH01
ATC
celecoxib; oral (coxibs)
2.2
7.1
76
385
S97
ICPC
Chronic ulcer skin
4.0
7.1
27
71
L04AA01
ATC
[U] ciclosporin; systemic
9.0
7.1
14
16
A41.8
ICD-10 Finland
Other specified sepsis
9.0
7.1
14
16
D06AX01
ATC
fusidic acid; topical (antibiotics for topical use)
2.7
7.0
48
193
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
4.2
7.0
25
62
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
4.1
7.0
26
67
R49.08
ICD-10 Finland
Other specified dysphonia
6.0
7.0
18
31
B03XA02
ATC
darbepoetin alfa; parenteral
7.7
7.0
15
20
R96
ICPC
Asthma
2.7
7.0
45
176
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
3.8
6.9
28
78
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
2.9
6.9
41
152
SPAT1262
SPAT
Handing over of treatment supplies
2.2
6.9
78
403
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
8.5
6.9
14
17
D07BA04
ATC
hydrocortisone and antiseptics; topical
2.6
6.9
51
216
XF404
NOMESCO Finland
Ambulatory ECG
2.7
6.9
47
189
M01AH02
ATC
rofecoxib; oral
2.4
6.9
58
261
A46
ICD-10 Finland
Erysipelas
2.4
6.9
58
261
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
3.3
6.9
33
106
TQW99
NOMESCO Finland
Other minor procedure on skin
3.7
6.8
28
79
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
9.5
6.8
13
14
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
9.5
6.8
13
14
FM1DG
NOMESCO Finland
Very extensive MRI examination of heart with high intesity magnet
9.5
6.8
13
14
R13
ICD-10 Finland
Dysphagia
3.2
6.8
34
112
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.1
6.8
82
438
TKC20
NOMESCO Finland
Catheterisation of bladder
3.1
6.8
35
118
J01DA09
ATC
[U] cefadroxil; inhalant, oral
1.9
6.8
115
699
QXB99
SPAT
NA
40.7
6.8
8
*
TGD04
NOMESCO Finland
Needle biopsy of the lungs in bronchoscopy
40.7
6.8
8
*
DPA20
NOMESCO Finland
Trephine of frontal sinus
40.7
6.8
8
*
EB1WA
NOMESCO Finland
NA
17.0
6.8
10
6
J05AH02
ATC
oseltamivir; oral
17.0
6.8
10
6
C82.1
ICD-10 Finland
Follicular lymphoma grade II
17.0
6.8
10
6
RS230
NOMESCO Finland
NA
17.0
6.8
10
6
R05FB02
ATC
cough suppressants and expectorants
1.8
6.8
145
955
A03FA02
ATC
cisapride; oral, rectal
3.0
6.8
38
134
G44.2
ICD-10 Finland
Tension-type headache
2.3
6.8
67
327
H66.9
ICD-10 Finland
Otitis media, unspecified
2.8
6.7
42
158
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.9
6.7
122
759
K29.3
ICD-10 Finland
Chronic superficial gastritis
5.3
6.7
19
37
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
3.9
6.7
26
70
YNB10
NOMESCO Finland
Collection of stem cells for transplant
22.9
6.7
9
*
E27.4
ICD-10 Finland
Other and unspecified adrenocortical insufficiency
22.9
6.7
9
*
C83.1
ICD-10 Finland
Mantle cell lymphoma
22.9
6.7
9
*
D07AB02
ATC
hydrocortisone butyrate; topical
1.9
6.7
119
736
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
3.4
6.7
31
97
K52.88
ICD-10 Finland
Other specified noninfective gastroenteritis and colitis
6.1
6.7
17
29
M03BC01
ATC
orphenadrine (citrate); systemic
1.9
6.7
103
604
R4190
NOMESCO Finland
Nutritional therapy
3.7
6.6
27
76
M79.6
ICD-10 Finland
Pain in limb
1.8
6.6
149
994
D69.3
ICD-10 Finland
Idiopathic thrombocytopenic purpura
12.5
6.6
11
9
JC2KB
NOMESCO Finland
Functional X-ray examination of swallowing
12.5
6.6
11
9
M05BX04
ATC
denosumab; parenteral
3.8
6.6
26
71
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
4.1
6.6
24
61
L08.9
ICD-10 Finland
Local infection of skin and subcutaneous tissue, unspecified
5.2
6.6
19
38
N17.9
ICD-10 Finland
Acute renal failure, unspecified
5.2
6.6
19
38
P01BA02
ATC
hydroxychloroquine; oral
2.7
6.6
43
170
L03AA13
ATC
pegfilgrastim; parenteral
3.5
6.5
28
83
XX1XW
NOMESCO Finland
Extensive written report from radiologist
7.6
6.5
14
19
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
70.9
6.4
7
*
K12.10
ICD-10 Finland
Stomatitis NOS
70.9
6.4
7
*
RS231
NOMESCO Finland
NA
70.9
6.4
7
*
RK320
NOMESCO Finland
NA
14.6
6.4
10
7
J32.1
ICD-10 Finland
Chronic frontal sinusitis
14.6
6.4
10
7
JN3CG
NOMESCO Finland
Extensive MRI examination of abdomen with high intensity magnet
14.6
6.4
10
7
DMB10
NOMESCO Finland
Radical maxillary antrotomy
14.6
6.4
10
7
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
2.6
6.4
47
196
Z04.9
ICD-10 Finland
Examination and observation for unspecified reason
4.1
6.4
23
58
A07EA06
ATC
budesonide; oral, local oral
4.1
6.4
23
58
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
5.3
6.4
18
35
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
4.0
6.4
24
63
Z50.5
ICD-10 Finland
Speech therapy
6.7
6.4
15
23
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
8.3
6.4
13
16
A12AA04
ATC
calcium carbonate; oral
8.3
6.4
13
16
XCK10
NOMESCO Finland
Photography of fundus of eye
2.6
6.4
44
178
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
5.7
6.4
17
31
GBB00
NOMESCO Finland
Tracheostomy
11.3
6.3
11
10
H57.9
ICD-10 Finland
Disorder of eye and adnexa, unspecified
11.3
6.3
11
10
RS224
NOMESCO Finland
NA
9.5
6.3
12
13
N06AX17
ATC
milnacipran; oral
9.5
6.3
12
13
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
9.5
6.3
12
13
M54.2
ICD-10 Finland
Cervicalgia
3.0
6.3
34
119
GD1BA
NOMESCO Finland
Extensive X-ray examination of thorax
18.3
6.3
9
5
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
18.3
6.3
9
5
J05AB09
ATC
famciclovir; oral
18.3
6.3
9
5
J01GB01
ATC
tobramycin; inhalant, parenteral
+∞
6.3
6
*
D83.1
ICD-10 Finland
Common variable immunodeficiency with predominant immunoregulatory T-cell disorders
+∞
6.3
6
*
Z94.2
ICD-10 Finland
Lung transplant status
+∞
6.3
6
*
4AA24
NOMESCO Finland
NA
+∞
6.3
6
*
D83.8
ICD-10 Finland
Other common variable immunodeficiencies
+∞
6.3
6
*
D84.8
ICD-10 Finland
Other specified immunodeficiencies
+∞
6.3
6
*
2AA01
NOMESCO Finland
NA
+∞
6.3
6
*
DHB50
NOMESCO Finland
Turbinoplasty
4.6
6.2
20
45
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
2.7
6.2
43
173
JA1AE
NOMESCO Finland
Ultrasound examination of groin and abdominal wall
5.5
6.2
17
32
SHA03
NOMESCO Finland
Correction of physiology of bite - demanding therapy visit
4.4
6.2
21
50
4859X
ICD-9 Finland
Bronchopneumonia, organism unspecified[PNEUMONIA NUD]
5.9
6.2
16
28
F32.00
ICD-10 Finland
Mild depressive episode without somatic syndrome
3.9
6.2
24
65
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
2.5
6.2
47
202
K07.60
ICD-10 Finland
Snapping jaw
3.3
6.2
29
92
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.8
6.2
37
139
J01EA01
ATC
trimethoprim; systemic
1.9
6.1
101
606
N06AX16
ATC
venlafaxine; oral
2.2
6.1
67
340
R42
ICD-10 Finland
Dizziness and giddiness
2.0
6.1
88
503
E000001
ATC
NA
1.9
6.1
91
526
D07AA02
ATC
hydrocortisone; topical
2.1
6.1
69
356
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
5.0
6.1
18
37
WX402
NOMESCO Finland
General anaesthesia
2.0
6.1
82
453
B01AB05
ATC
enoxaparin; parenteral
1.8
6.1
113
706
B00.10
ICD-10 Finland
Herpes simplex facialis
12.8
6.1
10
8
D47.2
ICD-10 Finland
Monoclonal gammopathy of undetermined significance (MGUS)
12.8
6.1
10
8
L30.9
ICD-10 Finland
Dermatitis, unspecified
2.0
6.1
79
434
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
2.9
6.1
35
127
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
303
246
37.17
307.65
5.0
1.7
0.8
1.5
g/l
3.31
282
230
170
18
153.06
307.65
3.0
1.4
—
—
—
0
0
164
18
144.46
307.65
2.9
1.4
12.4
9.3
%
0.98
110
12
132
27
69.35
235.67
2.8
1.3
578.7
712.4
e6/l
0.41
105
20
128
26
68.95
228.61
2.9
1.3
0.2
0.2
e9/l
0.38
105
20
109
30
47.93
180.39
2.7
1.6
706.8
714.4
e6/l
0.02
18
13
185
254
11.82
139.08
2.0
1.2
50.9
222.5
u/ml
1.18
142
233
320
870
10.76
132.14
5.2
1.4
1.2
2.2
g/l
19.71
264
540
69
12
67.98
124.78
1.2
1.1
—
—
—
0
0
68
12
66.82
122.60
1.2
1.1
95.4
89.4
%
0.22
68
12
183
336
8.60
105.25
4.1
2.6
0.2
0.2
g/l
2.81
183
319
91
70
16.12
98.57
6.6
8.6
532.5
193.3
iu/ml
0.60
20
11
114
132
11.30
94.87
1.8
1.6
0.2
0.2
g/l
0.25
102
127
116
140
10.89
93.58
1.8
1.5
1.1
1.2
g/l
0.61
107
134
86
0
+∞
93.09
1.9
0.0
1.6
—
mg/l
—
75
0
86
0
+∞
93.09
1.9
0.0
0.8
—
mg/l
—
66
0
86
0
+∞
93.09
1.9
0.0
1.5
—
mg/l
—
55
0
86
0
+∞
93.09
1.9
0.0
2.6
—
mg/l
—
63
0
86
0
+∞
93.09
1.9
0.0
1.5
—
mg/l
—
56
0
86
0
+∞
93.09
1.9
0.0
0.7
—
mg/l
—
61
0
86
0
+∞
93.09
1.9
0.0
1.2
—
mg/l
—
70
0
86
0
+∞
93.09
1.9
0.0
0.6
—
mg/l
—
63
0
86
0
+∞
93.09
1.9
0.0
2.2
—
mg/l
—
60
0
86
0
+∞
93.09
1.9
0.0
1.2
—
mg/l
—
65
0
169
338
7.49
88.12
2.7
1.8
—
—
—
0
0
164
341
7.06
81.69
2.8
1.9
—
—
—
0
0
77
61
15.08
81.54
5.5
4.7
7644.4
4287.8
u/ml
—
7
6
192
484
6.25
77.75
3.2
1.9
—
—
—
0
0
128
220
7.79
76.12
3.1
1.5
—
—
—
0
0
81
84
11.59
72.08
2.7
3.0
—
—
—
0
0
81
90
10.80
68.54
2.8
1.8
—
—
—
0
0
70
64
12.81
67.59
1.5
1.3
—
—
—
0
0
70
64
12.81
67.59
1.5
1.3
—
—
—
0
0
80
91
10.52
66.48
2.6
1.8
—
—
—
0
0
125
241
6.84
65.96
4.3
2.7
61.5
67.3
g/l
10.09
120
223
399
2145
10.03
62.06
31.7
9.2
3.8
4.0
e9/l
0.62
394
1865
68
68
11.64
61.75
2.6
1.8
—
—
—
0
0
63
61
11.88
58.37
2.3
1.7
—
—
—
0
0
54
45
13.53
54.95
2.2
1.8
—
—
—
0
0
47
31
16.85
54.47
4.6
4.0
—
—
—
0
0
61
63
11.08
53.99
1.9
1.5
—
—
—
0
0
51
40
14.29
53.76
2.3
1.8
—
—
—
0
0
57
54
11.97
53.47
2.2
1.7
—
—
—
0
0
154
434
4.92
52.18
4.0
2.3
22.0
23.6
%
0.58
146
377
53
5
120.15
50.00
3.0
1.8
—
—
—
0
0
63
80
9.02
47.65
1.7
1.2
—
—
—
0
0
43
31
15.26
47.40
2.0
1.9
—
—
—
0
0
83
149
6.63
46.11
3.0
1.6
—
—
—
0
0
209
806
4.03
45.48
3.2
2.1
2.9
3.0
mg/l
0.33
198
689
303
1522
4.17
44.31
20.4
6.3
1.2
1.2
mmol/l
2.66
293
1390
298
1497
4.06
43.16
4.7
2.4
83.7
76.0
nmol/l
4.33
290
1349
65
100
7.45
41.63
5.2
2.7
0.3
0.8
g/l
0.71
57
93
67
112
6.87
39.67
5.5
2.3
3.1
3.1
g/l
0.06
55
92
220
946
3.65
39.44
5.9
3.0
0.2
0.5
e6/l
2.45
185
704
69
120
6.63
39.32
5.4
2.2
3.0
3.7
g/l
4.24
55
90
69
120
6.63
39.32
5.4
2.2
—
—
—
0
0
69
120
6.63
39.32
5.4
2.2
7.3
7.4
g/l
0.09
55
96
308
1669
3.80
37.84
19.9
6.9
1.2
1.2
mmol/l
0.89
274
1425
56
81
7.77
37.78
1.7
1.7
—
—
—
0
0
53
74
8.00
36.84
7.8
4.4
18.9
26.6
mg/l
1.05
39
59
53
74
8.00
36.84
7.8
4.4
35.9
140.7
mg/l
0.65
38
60
64
111
6.57
36.48
5.5
2.3
6.8
10.1
g/l
7.65
56
99
248
1200
3.44
35.93
6.5
3.2
—
—
—
0
0
43
48
9.82
35.67
3.9
1.8
—
—
—
0
0
151
537
3.76
35.63
13.2
4.2
0.8
0.8
mmol/l
0.45
146
508
120
364
4.16
35.57
3.3
1.9
312.4
364.9
nmol/l
1.86
111
343
146
510
3.78
35.35
2.6
2.3
147.5
122.5
ug/g
0.28
122
401
274
1422
3.45
35.11
12.1
4.7
34.7
36.4
g/l
4.58
268
1344
59
98
6.80
35.03
5.2
2.4
38.8
38.7
g/l
0.06
54
87
41
44
10.17
34.99
2.6
1.7
—
—
—
0
0
44
52
9.29
34.96
2.6
1.6
—
—
—
0
0
40
42
10.37
34.67
4.1
1.9
—
—
—
0
0
317
1814
3.66
34.34
12.4
6.4
10.0
10.8
umol/l
0.77
312
1716
35
31
12.18
33.97
3.5
1.1
—
—
—
0
0
35
32
11.79
33.28
3.5
1.1
—
—
—
0
0
402
2743
6.26
32.92
22.4
7.3
83.8
80.5
u/l
0.78
396
2567
33
28
12.66
32.88
1.7
1.2
0.3
0.1
u/ml
—
22
10
399
2717
5.92
32.48
13.6
4.0
12.7
10.6
mm/h
2.00
394
2502
66
133
5.66
32.12
2.9
1.2
41.7
37.6
u/l
0.75
61
119
59
118
5.62
28.86
2.7
2.6
1.3
1.5
g/l
0.33
50
103
117
406
3.56
27.92
3.9
3.5
6.1
6.7
umol/l
0.21
107
353
44
69
6.97
27.43
8.2
3.8
56.8
56.3
%
0.07
44
69
29
27
11.43
27.15
1.9
1.2
—
—
—
0
0
240
1291
2.88
26.37
2.6
1.9
96.8
96.9
pmol/l
0.02
147
657
278
1620
2.94
26.18
5.4
2.7
200.5
98.3
ug/l
2.10
270
1502
40
63
6.88
24.79
3.0
2.0
125.9
130.3
g/l
0.24
15
43
24
19
13.30
24.78
2.6
3.5
28.1
29.4
umol/l
0.15
24
19
86
262
3.84
24.72
19.7
7.7
1.2
1.3
mmol/l
0.12
80
249
23
17
14.22
24.69
2.8
1.8
—
—
—
0
0
171
790
2.90
24.69
3.5
1.9
1.6
1.1
mg/l
0.52
142
606
23
18
13.43
23.89
2.8
1.7
—
—
—
0
0
23
19
12.72
23.13
2.8
1.8
—
—
—
0
0
311
2005
2.87
22.79
13.6
4.8
6.6
6.6
mmol/l
0.08
301
1861
25
25
10.54
22.24
2.6
1.7
—
—
—
0
0
40
72
6.01
21.73
2.5
1.8
—
—
—
0
0
22
19
12.13
21.50
1.7
1.5
—
—
—
0
0
36
59
6.56
21.45
1.7
1.4
—
—
—
0
0
18
11
17.02
21.22
1.8
2.4
—
—
—
0
0
130
560
2.87
20.88
3.9
2.7
1.6
0.9
e6/l
1.16
69
306
125
531
2.89
20.57
4.1
2.9
2.9
2.5
e6/l
0.15
65
278
19
14
14.14
20.34
1.8
1.6
—
—
—
0
0
18
13
14.39
19.45
2.9
1.3
—
—
—
0
0
60
168
3.98
19.24
1.8
1.4
—
—
—
0
0
39
77
5.46
19.20
3.6
1.4
—
—
—
0
0
153
749
2.60
18.84
2.0
1.4
23.6
21.7
nmol/l
0.56
142
632
164
832
2.55
18.73
5.0
2.9
1416.0
926.4
ng/l
0.75
152
685
65
201
3.62
18.04
23.8
4.6
24.1
24.1
mmol/l
0.06
57
192
39
83
5.06
17.64
1.8
1.4
—
—
—
0
0
86
330
3.00
16.74
2.7
2.6
28.9
33.8
u/l
0.45
68
279
24
33
7.63
16.68
1.3
1.2
—
—
—
0
0
36
75
5.14
16.67
1.9
1.4
85.2
110.4
u/ml
—
7
10
94
383
2.85
16.38
17.2
7.1
104.1
104.1
mmol/l
0.00
94
373
180
1003
2.34
16.23
3.5
2.1
112.1
184.0
u/l
1.84
173
945
19
20
9.88
16.22
1.7
1.4
—
—
—
0
0
46
120
4.16
16.18
1.3
1.1
—
—
—
0
0
83
318
2.98
16.17
14.9
9.9
1.0
1.2
mmol/l
0.19
68
251
56
169
3.65
16.06
2.2
1.7
—
—
—
0
0
25
39
6.74
15.54
2.8
1.7
—
—
—
0
0
25
39
6.74
15.54
2.8
1.7
—
—
—
0
0
25
39
6.74
15.54
2.8
1.7
—
—
—
0
0
83
326
2.90
15.42
20.1
4.5
1.8
2.1
mmol/l
0.20
75
254
45
120
4.06
15.36
1.5
1.3
—
—
—
0
0
25
40
6.57
15.17
1.7
1.3
—
—
—
0
0
30
58
5.48
15.07
1.6
1.1
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
36
82
4.69
15.01
6.3
4.0
0.4
0.4
u/ml
0.03
25
43
26
45
6.08
14.63
4.3
1.4
—
—
—
0
0
26
45
6.08
14.63
4.3
1.4
—
—
—
0
0
26
45
6.08
14.63
4.3
1.4
—
—
—
0
0
195
1166
2.21
14.44
5.5
3.3
2.3
2.4
mmol/l
2.52
175
1029
160
884
2.27
14.38
6.9
2.7
326.1
5654.0
umol/l
3.08
146
769
38
95
4.28
14.11
1.7
1.4
—
—
—
0
0
25
44
5.96
13.82
4.4
1.4
—
—
—
0
0
25
44
5.96
13.82
4.4
1.4
—
—
—
0
0
261
1774
2.15
13.67
7.5
4.7
0.0
0.0
estimate
0.00
69
352
57
193
3.24
13.63
4.4
2.8
240.8
162.2
ng/l
0.39
49
179
118
585
2.39
13.54
5.1
3.4
108.5
237.9
ng/l
1.05
82
414
25
45
5.83
13.51
4.4
1.4
—
—
—
0
0
13
10
13.36
13.42
5.2
5.6
—
—
—
0
0
38
100
4.06
13.18
3.9
2.0
213.6
285.6
ug/l
0.36
32
93
41
115
3.83
13.03
1.6
1.4
363.4
319.1
ug/g
0.64
24
67
261
1796
2.11
12.96
5.7
3.4
0.0
0.0
estimate
0.50
67
338
258
1771
2.10
12.85
5.7
3.4
0.0
0.0
estimate
0.00
66
345
111
551
2.36
12.61
1.9
1.7
1298.0
1220.6
nmol/l
0.33
96
415
78
328
2.67
12.61
4.5
3.1
—
—
—
0
0
47
150
3.39
12.33
20.7
13.7
—
—
—
0
0
34
90
4.01
11.70
1.8
1.4
139.7
236.4
u/ml
1.53
24
47
147
843
2.12
11.60
4.9
2.1
—
—
—
0
0
14
16
9.00
11.17
1.9
1.1
—
—
—
0
0
14
16
9.00
11.17
1.9
1.1
—
—
—
0
0
425
3718
4.94
10.89
50.8
12.2
18.8
21.2
mg/l
1.19
404
2838
42
139
3.23
10.39
1.8
2.3
—
—
—
0
0
34
98
3.68
10.39
1.5
1.4
1.8
0.0
iu/ml
0.47
11
15
42
140
3.21
10.27
1.6
1.3
0.5
1.1
u/ml
—
6
10
21
42
5.20
10.14
3.0
3.5
51.3
50.7
u/ml
—
6
11
15
22
7.02
9.79
2.5
2.7
75.9
120.3
ug/l
0.56
15
22
23
52
4.61
9.66
1.4
1.3
—
—
—
0
0
384
3229
2.46
9.54
55.0
15.0
14.1
13.5
%
8.10
384
3176
14
8
18.02
9.46
1.5
1.9
—
—
—
0
0
15
23
6.72
9.41
3.5
1.9
—
—
—
0
0
15
23
6.72
9.41
3.5
1.9
—
—
—
0
0
15
23
6.72
9.41
3.5
1.9
—
—
—
0
0
15
23
6.72
9.41
3.5
1.9
—
—
—
0
0
16
27
6.11
9.18
1.1
1.6
—
—
—
0
0
39
133
3.12
9.18
1.4
1.2
—
—
—
0
0
31
92
3.55
9.08
1.5
1.2
3.4
0.9
u/ml
—
5
5
15
24
6.43
9.05
1.1
1.2
—
—
—
0
0
13
18
7.41
8.89
1.6
1.8
10.6
10.8
umol/l
0.05
13
18
18
36
5.17
8.69
1.2
1.2
—
—
—
0
0
18
36
5.17
8.69
1.2
1.2
—
—
—
0
0
105
587
2.04
8.54
3.4
2.6
2.4
2.4
mmol/l
0.07
92
517
13
19
7.02
8.48
3.8
1.9
—
—
—
0
0
13
19
7.02
8.48
3.0
2.0
—
—
—
0
0
13
19
7.02
8.48
3.0
2.0
—
—
—
0
0
13
19
7.02
8.48
1.5
1.2
—
—
—
0
0
13
19
7.02
8.48
3.8
1.9
—
—
—
0
0
13
19
7.02
8.48
3.8
1.9
—
—
—
0
0
38
134
3.01
8.45
1.3
1.1
—
—
—
0
0
18
37
5.03
8.43
1.2
1.2
—
—
—
0
0
18
37
5.03
8.43
1.2
1.2
—
—
—
0
0
18
37
5.03
8.43
1.2
1.2
—
—
—
0
0
31
99
3.29
8.12
1.5
1.2
7.8
33.0
u/ml
—
7
9
12
7
17.58
8.11
3.2
5.6
—
—
—
0
0
35
122
3.03
7.94
1.4
1.2
1.2
7.1
u/ml
—
5
19
161
1061
1.81
7.88
3.7
2.5
54.0
55.8
u/l
0.31
156
981
27
82
3.44
7.65
4.9
3.3
24.5
24.8
mmol/l
0.11
27
70
112
665
1.92
7.58
1.3
1.3
29.0
35.5
iu/ml
0.30
29
209
55
248
2.39
7.58
15.4
4.1
1.3
1.6
mmol/l
0.24
44
176
17
37
4.74
7.46
2.0
1.4
—
—
—
0
0
12
9
13.66
7.42
1.2
1.2
—
—
—
0
0
35
129
2.86
7.21
1.5
1.2
—
—
—
0
0
11
16
7.03
7.18
1.7
1.3
—
—
—
0
0
11
16
7.03
7.18
1.1
1.1
784.2
1648.6
miu/ml
1.64
11
16
10
13
7.85
7.14
1.1
1.2
—
—
—
0
0
388
3394
2.19
6.85
35.7
11.2
87.5
85.7
ml/min/173m2
0.81
370
2730
11
17
6.61
6.80
4.3
1.8
—
—
—
0
0
24
74
3.37
6.65
1.1
1.1
—
—
—
0
0
220
1642
1.68
6.60
8.0
3.9
—
—
—
0
0
11
18
6.24
6.46
1.0
1.0
—
—
—
0
0
324
2694
1.76
6.38
4.9
3.3
—
—
—
0
0
16
38
4.33
6.34
4.4
1.8
32.8
32.7
pg
0.04
16
38
16
38
4.33
6.34
2.9
1.9
90.1
89.4
%
0.18
16
38
10
15
6.80
6.33
1.1
1.1
—
—
—
0
0
18
47
3.95
6.32
3.7
1.9
1.5
1.6
mmol/l
0.34
18
47
20
57
3.63
6.23
6.5
2.5
16.1
16.2
%
0.01
13
24
16
39
4.22
6.14
1.2
1.1
—
—
—
0
0
173
1231
1.67
6.11
5.0
3.2
24.5
29.6
ng/l
0.40
117
768
14
31
4.63
6.02
1.1
1.1
—
—
—
0
0
128
843
1.73
6.01
2.0
1.6
—
—
—
0
0
14
32
4.49
5.80
1.6
1.3
—
—
—
0
0
33
133
2.60
5.76
2.4
1.7
9.3
9.9
u/l
0.07
28
106
102
642
1.77
5.57
1.3
1.3
7.0
10.8
u/ml
0.29
23
252
8
5
16.25
5.43
5.6
5.2
—
—
—
0
0
8
5
16.25
5.43
5.0
6.8
—
—
—
0
0
15
39
3.95
5.30
2.1
1.3
—
—
—
0
0
18
54
3.43
5.22
1.4
1.1
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
10
19
5.36
5.06
1.5
1.2
—
—
—
0
0
140
985
1.62
4.98
1.4
1.4
0.5
1.7
u/ml
3.47
22
277
28
113
2.58
4.90
5.7
1.8
—
—
—
0
0
9
10
9.16
4.80
1.3
1.5
—
—
—
0
0
22
79
2.88
4.78
1.4
1.3
—
—
—
0
0
135
955
1.60
4.64
7.0
3.6
0.0
0.0
estimate
0.00
64
345
51
274
1.97
4.55
2.7
2.4
70.2
73.3
ml/min/173m2
0.14
21
115
45
231
2.06
4.54
1.4
1.3
—
—
—
0
0
14
39
3.67
4.52
1.2
1.1
—
—
—
0
0
12
30
4.08
4.46
4.6
2.1
—
—
—
0
0
18
60
3.09
4.45
1.2
1.3
1.8
3.4
u/ml
—
6
26
9
12
7.63
4.37
1.1
1.1
—
—
—
0
0
9
12
7.63
4.37
1.1
1.2
—
—
—
0
0
7
6
11.83
4.29
1.7
1.2
—
—
—
0
0
14
41
3.49
4.22
1.2
1.1
—
—
—
0
0
11
27
4.15
4.18
3.0
5.7
99.3
97.0
%
0.05
11
27
9
13
7.04
4.18
1.1
1.2
—
—
—
0
0
17
58
3.01
4.05
1.2
1.2
1.3
1.3
u/ml
—
7
18
332
2922
1.55
3.83
5.3
4.0
14.8
14.6
pmol/l
0.76
319
2679
6
5
12.14
3.77
1.5
1.2
—
—
—
0
0
133
979
1.51
3.72
1.7
1.7
1.4
1.4
mmol/l
0.07
125
835
8
12
6.77
3.69
1.6
1.0
—
—
—
0
0
8
12
6.77
3.69
2.0
1.3
13.5
13.0
u/l
—
8
12
8
13
6.24
3.51
1.1
1.3
—
—
—
0
0
6
6
10.11
3.50
1.2
1.3
—
—
—
0
0
98
683
1.56
3.50
2.0
1.7
505.4
449.5
pmol/l
1.01
92
563
29
141
2.13
3.40
1.3
1.3
226.4
251.6
miu/ml
0.15
14
71
7
10
7.09
3.37
1.7
1.0
—
—
—
0
0
374
3423
1.61
3.22
6.1
4.8
1.8
2.2
mu/l
0.53
364
3168
7
11
6.45
3.19
1.0
1.4
—
—
—
0
0
14
50
2.86
3.11
2.7
1.3
16.0
3.4
ug/l
0.65
14
41
6
8
7.58
3.06
1.2
1.3
—
—
—
0
0
5
5
10.09
2.98
1.4
1.0
—
—
—
0
0
11
35
3.20
2.95
1.1
1.1
—
—
—
0
0
289
2537
1.40
2.86
5.2
3.2
61.4
43.3
u/l
2.23
280
2395
10
31
3.28
2.79
1.1
1.0
—
—
—
0
0
5
6
8.41
2.75
1.2
1.0
—
—
—
0
0
5
6
8.41
2.75
1.2
1.0
—
—
—
0
0
7
14
5.06
2.74
1.4
1.4
—
—
—
0
0
7
14
5.06
2.74
1.4
1.4
—
—
—
0
0
11
37
3.02
2.71
4.5
2.9
13.4
14.7
mu/l
0.15
11
37
9
24
3.81
2.68
1.2
1.0
—
—
—
0
0
170
1381
1.38
2.64
6.6
3.4
—
—
—
0
0
33
186
1.84
2.61
22.2
4.3
24.0
24.5
mmol/l
0.46
33
179
7
15
4.72
2.60
1.4
1.3
—
—
—
0
0
24
123
2.01
2.50
4.8
2.0
—
—
—
0
0
9
26
3.51
2.49
1.7
1.8
0.9
1.0
g/l
—
9
26
73
514
1.50
2.47
2.6
2.1
—
—
—
0
0
6
12
5.05
2.41
1.8
1.0
—
—
—
0
0
8
23
3.52
2.28
1.5
2.0
—
—
—
0
0
6
13
4.66
2.28
1.5
1.4
—
—
—
0
0
6
13
4.66
2.28
1.5
1.4
—
—
—
0
0
5
9
5.60
2.22
2.4
1.9
—
—
—
0
0
36
221
1.68
2.17
2.4
2.0
—
—
—
0
0
15
70
2.18
2.00
2.2
1.1
50.5
31.3
iu/ml
—
6
18
21
114
1.88
1.90
2.0
1.7
—
—
—
0
0
120
966
1.33
1.89
5.5
4.0
22.5
9.1
mg/mmol
1.21
75
595
18
93
1.98
1.88
1.5
1.3
—
—
—
0
0
25
411
0.58
1.87
10.1
5.9
—
—
—
0
0
42
281
1.55
1.82
2.4
2.0
—
—
—
0
0
65
476
1.43
1.82
2.5
2.0
—
—
—
0
0
38
251
1.56
1.75
3.1
2.3
13.6
13.9
nmol/l
0.08
33
227
23
377
0.59
1.71
1.9
1.6
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
6
19
3.19
1.66
3.0
1.6
177.3
124.4
%
—
6
19
5
14
3.60
1.62
1.6
3.6
180.2
215.3
u/l
—
5
14
5
14
3.60
1.62
1.2
1.0
—
—
—
0
0
24
148
1.66
1.47
1.8
1.5
294.3
283.6
mu/l
0.12
24
136
6
22
2.75
1.44
4.3
3.8
—
—
—
0
0
42
302
1.43
1.33
1.9
1.3
94.4
153.7
iu/ml
0.74
17
128
44
323
1.40
1.26
4.0
4.1
36.0
21.1
ug/l
0.17
37
267
8
36
2.24
1.25
1.0
1.2
—
72.2
—
0
5
33
234
1.44
1.15
2.3
2.2
6.2
5.8
ug/l
0.07
28
205
8
147
0.54
1.05
1.3
1.9
—
—
—
0
0
11
61
1.82
0.99
1.2
1.1
—
—
—
0
0
427
4194
1.57
0.88
64.4
18.2
130.1
136.0
g/l
12.04
427
4139
6
30
2.01
0.87
1.2
1.6
—
—
—
0
0
344
3297
1.20
0.83
6.2
5.3
39.0
39.1
mmol/mol
0.05
330
3092
349
3613
0.84
0.77
4.8
4.2
4.7
4.8
mmol/l
0.60
336
3383
0
27
0.00
0.77
0.0
1.5
—
7.5
—
0
14
364
3513
1.21
0.77
50.8
12.9
39.4
40.4
%
2.84
308
2719
335
3469
0.86
0.68
4.6
3.8
1.4
1.3
mmol/l
2.02
322
3221
52
433
1.23
0.66
2.5
2.8
0.5
0.7
ug/l
2.70
38
261
20
147
1.38
0.63
1.7
2.2
303.6
4021.1
u/l
—
5
53
11
71
1.56
0.62
2.0
1.8
—
—
—
0
0
34
418
0.80
0.59
4.9
4.2
30.3
32.2
%
0.43
28
282
350
3595
0.87
0.53
4.7
4.2
1.5
1.5
mmol/l
0.40
333
3351
18
140
1.30
0.42
2.3
1.4
—
—
—
0
0
359
3659
0.90
0.35
5.3
4.6
2.7
2.9
mmol/l
1.42
342
3405
75
686
1.11
0.33
1.6
1.4
—
—
—
0
0
16
184
0.86
0.17
1.4
1.5
—
—
—
0
0
63
593
1.07
0.17
3.2
4.1
16.8
21.0
%
2.46
29
255
7
63
1.11
0.17
1.6
1.5
—
—
—
0
0
8
72
1.11
0.16
1.1
1.3
—
—
—
0
0
25
228
1.10
0.13
1.0
1.0
—
—
—
0
0
347
3495
0.97
0.08
4.9
4.2
5.9
5.8
mmol/l
0.42
337
3222
9
105
0.85
0.06
1.6
1.6
—
—
—
0
0
49
499
0.98
0.02
1.6
1.9
1.6
1.4
%
0.73
42
448
9
95
0.95
0.00
1.2
1.4
—
—
—
0
0
0
6
0.00
0.00
0.0
3.2
—
59.2
—
0
6
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
9
95
0.95
0.00
1.2
1.4
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
9
95
0.95
0.00
1.2
1.4
—
—
—
0
0
7
72
0.97
0.00
1.7
5.0
314.6
371.6
umol/l
—
7
64
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint D3_IMMUDEFANTIBODYNAS and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| D3_IMMUDEFANTIBODYNAS | 3.692 [2.74, 4.98] | < 0.001 |
| Birth year | 0.998 [0.99, 1.01] | 0.678 |
During the follow-up period (1.1.1998 — 31.12.2019), 114 out of 759 females with D3_IMMUDEFANTIBODYNAS died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| D3_IMMUDEFANTIBODYNAS | 4.194 [2.91, 6.04] | < 0.001 |
| Birth year | 0.987 [0.98, 1.0] | 0.01 |
During the follow-up period (1.1.1998 — 31.12.2019), 101 out of 537 males with D3_IMMUDEFANTIBODYNAS died.
Mortality risk
Mortality risk for people of age
years, who have D3_IMMUDEFANTIBODYNAS.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.49% | 0.783% |
| 5 | 2.474% | 4.738% |
| 10 | 6.1% | 11.305% |
| 15 | 11.228% | 20.533% |
| 20 | 18.82% | 33.16% |
Relationships between endpoints
↥Index endpoint: D3_IMMUDEFANTIBODYNAS – Other and unspecified immunodeficiencies with predominantly antibody defects
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data